SemenBoost

Supplements

CoQ10 and male fertility

CoQ10 trials have reported changes in semen parameters. Evidence that it improves pregnancy or live birth is uncertain.

Published
Modified
Clinician review
Not yet

Short answer

Coenzyme Q10 is an antioxidant that has been tested in men with abnormal semen parameters. Some randomised trials report improvements in concentration and motility over a few months. That does not establish that CoQ10 improves the chance of pregnancy or live birth. SemenBoost does not say that CoQ10 boosts fertility.

Key takeaways

  • It has been studied as ubiquinone, often around 200 mg daily for several months. That describes trials, not a dose to start.
  • Motility and concentration are the parameters most often reported.
  • Pregnancy data for CoQ10 alone are sparse.
  • It is not a treatment for azoospermia, steroid use, or a blockage.

What it is

CoQ10 is present in mitochondria, including in sperm, and can act as an antioxidant. The theory is that oxidative stress damages sperm membranes and DNA, so an oral antioxidant might change semen measurements. A theory is why researchers ran trials. It is not a result.

What studies show

Small and medium trials, including work often cited from infertility clinics, have reported higher sperm concentration and better motility after CoQ10 compared with placebo, typically over about three to six months. Morphology findings are less consistent. The trials do not share one dose or one population. Commonly cited protocols have used about 200 mg a day. Other protocols differ. SemenBoost is not recommending 200 mg.

Pregnancy and live birth

Most CoQ10 semen trials were not designed to answer whether a baby was born. In the Cochrane review of antioxidants as a class, live birth evidence was very low certainty and depended on trials with a high risk of bias. CoQ10 cannot be lifted out of that uncertainty and sold as a fertility outcome.

Safety

CoQ10 is usually well tolerated in trials. It can interact with warfarin and may lower blood pressure slightly. People on anticoagulants, chemotherapy, or fertility drugs should ask the prescriber before adding it. Gastrointestinal upset is the adverse effect antioxidant reviews flag most often, for the class rather than for CoQ10 alone.

Limits

Publication bias, small samples and short follow-up are the usual problems. A shop that quotes one positive motility trial and skips pregnancies is not summarising the evidence. No commercial CoQ10 product is listed on this page.

Evidence

Limited evidence

There are randomised trials reporting semen-parameter changes. They are not large or consistent enough, and they do not settle fertility outcomes.

Semen parameters

Limited evidence

Concentration and motility have improved in some placebo-controlled trials. Doses and results vary, and morphology is inconsistent.

Pregnancy and live birth

Insufficient evidence

Pregnancy and live birth have not been reliably demonstrated for CoQ10 specifically. Class-level antioxidant evidence is very low certainty.

A change in a semen measurement is not the same finding as a pregnancy or a live birth.

Related

Sources

  1. Antioxidants for male subfertility — Cochrane, 2022
  2. Fertility problems: assessment and treatment (NG257) — NICE, 2026
How this page was prepared

Drafted with automated research assistance and checked against the cited primary sources. A named clinician has not reviewed this page. Medical review is pending. Changes to reference values are not published automatically.